Cargando…

Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease

A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Szu-Yuan, Tang, Yu-Shuo, Chan, Yu-Jiun, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434020/
https://www.ncbi.nlm.nih.gov/pubmed/32433343
http://dx.doi.org/10.1097/JCMA.0000000000000356
_version_ 1783572061471375360
author Li, Szu-Yuan
Tang, Yu-Shuo
Chan, Yu-Jiun
Tarng, Der-Cherng
author_facet Li, Szu-Yuan
Tang, Yu-Shuo
Chan, Yu-Jiun
Tarng, Der-Cherng
author_sort Li, Szu-Yuan
collection PubMed
description A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic.
format Online
Article
Text
id pubmed-7434020
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74340202020-08-18 Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease Li, Szu-Yuan Tang, Yu-Shuo Chan, Yu-Jiun Tarng, Der-Cherng J Chin Med Assoc Review Articles A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic. Lippincott Williams & Wilkins 2020-05-19 2020-07 /pmc/articles/PMC7434020/ /pubmed/32433343 http://dx.doi.org/10.1097/JCMA.0000000000000356 Text en Copyright © 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Review Articles
Li, Szu-Yuan
Tang, Yu-Shuo
Chan, Yu-Jiun
Tarng, Der-Cherng
Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title_full Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title_fullStr Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title_full_unstemmed Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title_short Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
title_sort impact of the covid-19 pandemic on the management of patients with end-stage renal disease
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434020/
https://www.ncbi.nlm.nih.gov/pubmed/32433343
http://dx.doi.org/10.1097/JCMA.0000000000000356
work_keys_str_mv AT liszuyuan impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease
AT tangyushuo impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease
AT chanyujiun impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease
AT tarngdercherng impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease